TERT and renal pelvis/ureter urothelial carcinoma: In 14 UTUC tumor specimens, the sequencing result revealed TERT promoter mutations in 3/5 (60%) renal pelvic cancer and 1/9 (11%) ureter cancer, and all of them were C228T mutations (Table 1 and 2).